Recombinant Antibodies for Infectious Diseases

There are many principles and applications of recombinant antibodies for infectious diseases. The preferred technology associated to recombinant antibody generation is mainly phage display. The adaptation of antibodies for infectious diseases is an area lacking information as most literature is focu...

Full description

Bibliographic Details
Other Authors: Lim, Theam Soon (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing 2017, 2017
Edition:1st ed. 2017
Series:Advances in Experimental Medicine and Biology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01695nmm a2200289 u 4500
001 EB001800846
003 EBX01000000000000000974344
005 00000000000000.0
007 cr|||||||||||||||||||||
008 180405 ||| eng
020 |a 9783319720777 
100 1 |a Lim, Theam Soon  |e [editor] 
245 0 0 |a Recombinant Antibodies for Infectious Diseases  |h Elektronische Ressource  |c edited by Theam Soon Lim 
250 |a 1st ed. 2017 
260 |a Cham  |b Springer International Publishing  |c 2017, 2017 
300 |a XVIII, 296 p. 26 illus., 22 illus. in color  |b online resource 
653 |a Diseases 
653 |a Immunospecificity 
653 |a Adaptive Immunity 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Advances in Experimental Medicine and Biology 
028 5 0 |a 10.1007/978-3-319-72077-7 
856 4 0 |u https://doi.org/10.1007/978-3-319-72077-7?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.0795 
082 0 |a 571.9646 
520 |a There are many principles and applications of recombinant antibodies for infectious diseases. The preferred technology associated to recombinant antibody generation is mainly phage display. The adaptation of antibodies for infectious diseases is an area lacking information as most literature is focused on oncology or autoimmunity. This project highlights the power and potential of antibody phage display for infectious diseases. In addition to that, supplementary information regarding technologies associated to antibody generation and engineering in the context of infectious disease will also help to provide greater insight to the potential of recombinant antibodies for infectious diseases